Dr. Jay M. Lee, MD

Dr. Lee practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Lee's NPI, 1952326654, was assigned on July 13, 2006. Dr. Lee graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Lee holds California license A96666.

Dr. Lee's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Lee's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Lee is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health. Dmand AI also links Dr. Lee to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 6 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Lee is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Lee's licenses on file in 5 states: California, District of Columbia, North Carolina, Massachusetts and Virginia.

Dmand AI lists esophagus, stomach, or upper small intestine surgery and lung resection among the conditions Dr. Lee treats.

CMS data shows 520 Medicare services from Dr. Lee across 7 procedure codes in 2024, for 239 Medicare patients. Medicare paid $102,321 for them.

CMS counts 239 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 69, with 54% women.

In 2024, Dr. Lee wrote 49 Medicare Part D claims for 20 patients. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $73 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 11 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lee, more than 42% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 42 papers to Dr. Lee, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Neoadjuvant Therapy. Dr. Lee has published most often in Nat Med. Dr. Lee's most frequent co-authors are Steven M. Dubinett, MD, Bruce Evan Johnson, MD and Paul Axtell Bunn, MD.

Dmand AI links Dr. Lee to 5 clinical trials. Conditions studied include Heart Diseases, Carcinoma, Non-Small-Cell Lung and Heart Failure. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 346 general payments to Dr. Lee from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Merck Sharp & Dohme Corporation paid the most, $179,784. It also lists 39 research payments totaling $68,751 from 2020 to 2025.

Dmand AI lists 3 awards for Dr. Lee.

Dr. Lee graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Lee is a member of AATS, ACS, ASCO, AAS, General Thoracic Surgical Club and International Association for the Study of Lung Cancer.

Dr. Lee is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.